drugset / Trial / NCT01548612
Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
In spite of the numerous studies on schizophrenia, its etiology and physiopathology remain unknown. Evidence suggests a possible implication of nitric oxide (NO) in schizophrenia. NO is a gas with unique chemistry and influences the release of neurotransmitters, learning, memory and neurodevelopment. Recent studies that investigated the role of NO in patients with schizophrenia found evidence that points to a disruption in NO-mediated neurotransmission in schizophrenia. Accordingly, we believe that the administration of sodium nitroprusside, an NO donor, will ameliorate schizophrenia symptoms.
Timeline
- Start
- 2006-02
- Primary completion
- 2009-06
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Nitroprusside | Unknown | 0.5 ug/kg | Intravenous |